Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jun 28;16(6):642–649. doi: 10.1111/j.1939-1676.2002.tb02402.x

Molecular Evidence Supporting Ehrlichia canis‐Like Infection in Cats

Edward B Breitschwerdt 1,✉, Anthony CG Abrams‐Ogg 2, Michael R Lappin 3, Dorothee Bienzle 2, Susan I Hancock 1, Sara M Cowan 1, Jennifer K Clooten 2, Barbara C Hegarty 1, Eleanor C Hawkins 1
PMCID: PMC7199470  PMID: 12465759

Abstract

Currently, the pathogenic role of Ehrlichia canis in cats has been proposed predominantly on the basis of the serologic evidence of natural infection and the infrequent detection of morulae‐like structures within the cytoplasm of leukocytes in cats. The purpose of this report was to provide molecular evidence supporting E cams‐like infection in 3 cats that had clinical manifestations consistent with canine ehrlichiosis but lacked antibodies to E canis antigens. Serum from all 3 cats contained antinuclear antibodies (ANAs). The predominant disease manifestation was polyarthritis in 1 cat and bone marrow hypoplasia or dysplasia, accompanied by pancytopenia or anemia and thrombocytopenia, in 1 cat each. The alignment of E canis partial 16S ribosomal DNA (rDNA; 382 nucleotide positions), amplified from EDTA blood samples from each cat, was identical to each other and was identical to a canine isolate of E canis (GenBank accession number AF373613). In 1 cat, concurrent treatment with corticosteroids may have interfered with the therapeutic effectiveness of doxycycline for the elimination of E canis‐like infection. To further define the spectrum of ehrlichiosis in cats, polymerase chain reaction (PCR) testing may be necessary until serologic testing is thoroughly validated in experimentally or naturally infected cats. In addition, until E canis has been isolated from cats and several tissue culture isolates are available from disparate geographic regions for detailed comparative genetic study, the molecular evidence presented in this study supporting E canis‐like infection in cats must be interpreted with caution.

Keywords: Antinuclear antibodies, Leukemia, Polyarthritis, Thrombocytopenia

References

  • 1. Rikihisa Y. The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 1991;4:286–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Walker DH, Dumler JS. Emergence of the Ehrlichioses as human health problems. Emerg Infect Dis 1996;2:18–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Stubbs CJ, Holland CJ, Reif JS, et al. Feline ehrlichiosis; literature review and serologic survey. Compend Cont Educ Pract Vet 2000;22:307–317. [Google Scholar]
  • 4. Charpentier F., Groulade P. Probable case of ehrlichiosis in a cat. Bull Acad Vet France 1986;59:287–290. [Google Scholar]
  • 5. Buoro IBJ, Atwell RB, Kiptoon J., et al. Feline anemia associated with Ehrlichia‐liks bodies in three domestic shorthaired cats. Vet Rec 1989;125:434–436. [DOI] [PubMed] [Google Scholar]
  • 6. Bouloy RP, Lappin MR, Holland CH, et al. Clinical ehrlichiosis in a cat. J Am Vet Med Assoc 1994;204:1475–1478. [PubMed] [Google Scholar]
  • 7. Beaufils JP, Marin‐Granel J., Jumelle P. Ehrlichia infection in cats: A review of three cases. Pratique Med Chir Anim Compagnie 1995;30:397–402. [Google Scholar]
  • 8. Almosny NRP, Massard CL. Feline ehrlichiosis—Review. Clin Vet 1999;4:30–32. [Google Scholar]
  • 9. Bjoersdorff A., Svendenius L., Owens JH, et al. Feline granulo‐cytic ehrlichiosis—A report of a new clinical entity and characterisation of the new infectious agent. J Small Anim Pract 1999;40:20–24. [DOI] [PubMed] [Google Scholar]
  • 10. Mattheman LA, Kelly PJ, Wray K., et al. Antibodies in cat sera from southern Africa react with antigens of Ehrlichia canis . Vet Rec 1996;138:364–365. [DOI] [PubMed] [Google Scholar]
  • 11. Peavy GM, Holland CJ, Dulta SK, et al. Suspected ehrlichial infection in five cats from a household. J Am Vet Med Assoc 1997; 210:231–234. [PubMed] [Google Scholar]
  • 12. Breitschwerdt EB, Hegarty BC, Hancock SI. Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaf‐feensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii . J Clin Microbiol 1998;36:2645–2651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kordick SK, Breitschwerdt EB, Hegarty BC, et al. Coinfection with multiple tick‐borne pathogens in a Walker Hound kennel in North Carolina. J Clin Microbiol 1999;37:2631–2638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Neer TM. Canine monocytic and granulocytic Ehrlichiosis In: Greene CE, ed. Infectious Diseases of the Dog and Cat, 2nd ed. Philadelphia , PA : WB Saunders; 1998: 139–147. [Google Scholar]
  • 15. Stockham SL, Schmidt DA, Curtis KS. Evaluation of granulocytic ehrlichiosis in dogs of Missouri, including serologic status to Ehrlichia canis, Ehrlichia equi and Borrelia burgdorferi . Am J Vet Res 1992;53:63–68. [PubMed] [Google Scholar]
  • 16. Suksawat J., Xuejie Y., Hancock SI, et al. Serologic and molecular evidence of coinfection with multiple vector‐borne pathogens in dogs from Thailand. J Vet Intern Med 2001;15:453–462. [DOI] [PubMed] [Google Scholar]
  • 17. Pearce CH, Conrad ME, Nolan PE, et al. Ehrlichiosis: A cause of bone marrow hypoplasia in humans. Am J Hemtol 1988;28:53–55. [DOI] [PubMed] [Google Scholar]
  • 18. Abort KC, Vukelja SJ, Smith CE, et al. Hemophagocytic syndrome: A cause of pancytopenia in human ehrlichiosis. Am J Hematol 1991;38:230–234. [DOI] [PubMed] [Google Scholar]
  • 19. Pisetsky D., Drayton D., Wu ZQ. Specificity of antibodies to bacterial DNA in the sera of healthy human subjects and patients with systemic lupus erythematosus. J Rheumatol 1999;26:1934–1938. [PubMed] [Google Scholar]
  • 20. Neujahr DC, Reich CF, Pisetsky DS. Immunostimulatory properties of genomic DNA from different bacterial species. Immunobiology 1999;200:106–119. [DOI] [PubMed] [Google Scholar]
  • 21. Wong SJ, Thomas JA. Cytoplasmic, nuclear and platelet auto‐antibodies in human granulocytic ehrlichiosis patients. J Clin Microbiol 1998;36:1959–1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Neer TM, Eddlestone SM, Gaunt SD, et al. Efficacy of enro‐floxacin for the treatment of experimentally induced Ehrlichia canis infection. J Vet Intern Med 1999;13:501–504. [DOI] [PubMed] [Google Scholar]
  • 23. Sainz A., Tesouro MA, Amusategui I., et al. Prospective comparative study of 3 treatment protocols using doxycycline or imidocarb dipropionate in dogs with naturally occurring ehrlichiosis. J Vet Intern Med 2000; 14:134–139. [DOI] [PubMed] [Google Scholar]
  • 24. Breitschwerdt EB, Hegarty BC, Hancock SI. Doxycycline hy‐clate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains. Antimicrob Agents Chemother 1998;42:362–368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Harrus S., Waner T., Aizenberg I., et al. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis . J Clin Microbiol 1998;36:73–76. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES